Matthew Scott Harris, Director at Altimmune, Inc. (ALT), sold 4,015 shares at $10.02 ($40K) on 2020-11-12, disclosed to the SEC on 2020-11-13.
Scheduled sale ($40k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |